David J. Kim, M.D.

StrokeDx provides portable, rapid, and non-invasive stroke detection and imaging tools.

CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. Our purpose We are supporting healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. Early identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes and heart attacks and improve outcomes for individuals and society.

FIGUR8 is the market leader for measuring musculoskeletal (MSK) health and injury recovery. Through its innovative biomotion Assessment Platform (bMAP) and objective progress reporting, FIGUR8 empowers payers, providers, and patients with valuable decision-making insights at every stage of the recovery process.

Mightier is a child-centered, evidence-based digital program that uses biometric feedback and game-based play to help children learn, practice, and apply lifelong coping skills. With both online and offline activities, Mightier supports the development of the whole child so kids can live healthier, happier lives. Developed at Boston Children’s Hospital and Harvard Medical School, Mightier is clinically proven to help kids ages 6 to 14 prepare for life's big emotions. To date, more than 2.5 million games have been played on the Mightier app by more than 100,000 kids. Mightier for Business provides employers, health plans and digital health partners with a solution by delivering immediate access to pediatric mental health services. Designed to complement existing employee mental health resources, Mightier for Business includes expanded support and services packages to support businesses and their employees.

Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease. Through its AI-empowered solutions, Cleerly supports comprehensive phenotyping of coronary artery disease, through its evaluation of advanced non-invasive CT imaging. Cleerly’s approach is grounded in nearly 20 years of science from landmark multi-center clinical trials. Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway.

The last decade has seen amazing progress in neuroscience, enabling researchers to envision a new generation of brain machine interfaces. These systems will be used to treat chronic diseases like Parkinsons, epilepsy, and Alzheimers. They will restore mobility to the paralyzed and speed recovery from a stroke. They may even allow us to control our mood and enhance our cognition. Rune Labs wants to build the software at the heart of these systems, and help accelerate the next wave of neuromodulation applications.

G-Tech Medical has developed a wireless wearable patch system that measures GI motility non-invasively.

Embr Labs is a Boston-based technology startup with patented wearable technology that goes beyond sensing. Our wearable thermal technology provides heating and cooling at the touch of a button and is already helping tens of thousands of people live better lives through personal temperature control. We are a science-driven team of interdisciplinary, collaborative, and compassionate people on a mission to harness the body’s natural response to temperature to enhance human wellbeing. Our technology was invented by the company’s founders while at MIT; we are backed by DigiTx Partners, Safar Partners, Bose Ventures and Intel Capital, and we have partnered with companies like Johnson & Johnson.

Savonix is the only digital neuropsychology platform in the market. We empower patients, providers, payers, and researchers with cognitive solutions to fight against dementia. Clinically validated, our cloud-based platform allows users to screen for cognitive health directly from their mobile device. Privacy Statement: https://savonix.com/terms-and-privacy/ For a demonstration of the cognitive solutions we offer: https://savonix.com/contact/

Neosensory, Inc. brings sensory augmentation to the masses via wearables. Expand your perception. Rewrite your human experience.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform, with over 650,000 devices sold to clinicians globally, allows them to detect earlier and with higher accuracy, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $165 million in funding from ARTIS Ventures, DigiTx Partners, Double Point Ventures, EDBI, Highland Capital Partners, LG Technology Ventures, Mayo Clinic, Morningside Technology Ventures Limited, NTTVC, Questa Capital, and others. For more information, visit www.ekohealth.com.

Eight and a half million Americans live with non-healing wounds. Caring for these conditions unfortunately relies heavily on guesswork and approximations, perpetuating expensive and ineffective treatments. Care providers simply do not have the tools necessary to accurately track wound healing over time. Tissue Analytics is bringing wound care into the 21st century by turning the common smartphone into a sophisticated imaging platform. Tissue Analytics has developed proprietary image analysis algorithms that completely standardize wound documentation, allowing clinicians to make more informed decisions and heal patients faster.

The leader in AI in radiotherapy treatment decision support Siris Medical, inc was founded with the vision of improving treatment delivery and outcomes for patients undergoing radiation therapy for cancer treatment. Siris predictive software informs clinicians of treatment plan outcomes in real-time, enabling data driven radiation oncology decision-making with Artificial Intelligence (AI). Siris Medical has two commercial products: QuickMatch and 510(k)-cleared PlanMD. These products leverage machine learning to connect each new patient to our growing market-leading oncology library of plan outcomes, with an opportunity to become the standard of care in treatment decision-making.

Savonix is the only digital neuropsychology platform in the market. We empower patients, providers, payers, and researchers with cognitive solutions to fight against dementia. Clinically validated, our cloud-based platform allows users to screen for cognitive health directly from their mobile device. Privacy Statement: https://savonix.com/terms-and-privacy/ For a demonstration of the cognitive solutions we offer: https://savonix.com/contact/

Sensoplex DBA Rover Health offers the first and only Remote Therapeutic Monitoring (RTM) system for gait and balance. Physical Therapists or other healthcare professionals can utilize our product for providing better care for their patients while increasing revenue, based on new Medicare CPT codes, when the patients are away from the doctor's office. We also offer a system for the Senior Living Centers to help assess the risk of fall for their elderly residents and help minimize the risk.

StrokeDx provides portable, rapid, and non-invasive stroke detection and imaging tools.

CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. Our purpose We are supporting healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. Early identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes and heart attacks and improve outcomes for individuals and society.

FIGUR8 is the market leader for measuring musculoskeletal (MSK) health and injury recovery. Through its innovative biomotion Assessment Platform (bMAP) and objective progress reporting, FIGUR8 empowers payers, providers, and patients with valuable decision-making insights at every stage of the recovery process.

Mightier is a child-centered, evidence-based digital program that uses biometric feedback and game-based play to help children learn, practice, and apply lifelong coping skills. With both online and offline activities, Mightier supports the development of the whole child so kids can live healthier, happier lives. Developed at Boston Children’s Hospital and Harvard Medical School, Mightier is clinically proven to help kids ages 6 to 14 prepare for life's big emotions. To date, more than 2.5 million games have been played on the Mightier app by more than 100,000 kids. Mightier for Business provides employers, health plans and digital health partners with a solution by delivering immediate access to pediatric mental health services. Designed to complement existing employee mental health resources, Mightier for Business includes expanded support and services packages to support businesses and their employees.